|Year : 2020 | Volume
| Issue : 4 | Page : 522-525
Factors affecting mammography screening utilization among educated women in Al Beheira governorate, Egypt
Basem M M. Salama
Department of Community Medicine, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt
|Date of Submission||18-Jan-2020|
|Date of Acceptance||03-Jul-2020|
|Date of Web Publication||28-Oct-2020|
Dr. Basem M M. Salama
Department of Community Medicine, Damietta Faculty of Medicine, Al-Azhar University, Cairo
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Breast cancer (BC) is the leading cancer in women worldwide and is increasing particularly in developing countries where the majority of cases are diagnosed in late stages. Early detection at an early stage by mammography screening leads to better prognosis and improves the survival rate for this malignancy. The aim of the study was to analyze factors that affect mammography screening utilization among educated women. Patients and Methods: A total of 700 educated women aged 40 years and older were included in a community-based cross-sectional interview survey that was conducted in between June 2017 and August 2018 in Al Beheira governorate Egypt. Results: Multivariate logistic regression revealed that lack of knowledge about mammography (odds ratio [OR] = 9.8), education level (OR = 6.0), employment status (OR = 3.5), cancer fatalism (OR = 3.0), residence (OR = 2.8), fear of embarrassment (OR = 2.6, fear of positive result (OR = 2.4), family income (OR = 1.9), and health insurance (OR = 1.8) were significant (P < 0.05) predictors of mammography screening utilization. Conclusion: Mammography utilization screening rate is low. Lack of knowledge about mammography, cultural norms, and socioeconomic factors were barriers to mammography screening.
Keywords: Breast, cancer, mammography, screening and factors
|How to cite this article:|
M. Salama BM. Factors affecting mammography screening utilization among educated women in Al Beheira governorate, Egypt. Indian J Community Med 2020;45:522-5
|How to cite this URL:|
M. Salama BM. Factors affecting mammography screening utilization among educated women in Al Beheira governorate, Egypt. Indian J Community Med [serial online] 2020 [cited 2022 May 24];45:522-5. Available from: https://www.ijcm.org.in/text.asp?2020/45/4/522/299423
| Introduction|| |
Breast cancer (BC), the most frequent malignancy in women, is also the second most frequent among the entire world population. In the year 2018, about 2.1 million women worldwide were diagnosed with BC for the first time. The most frequent cancer affecting women, one of four female cancer patients, was BC and constitutes 14% of female cancer deaths. Developing and low-income countries showed sharp slopes of increasing BC mortality rate.
The WHO has reported that the incidence of BC is increasing by between 1.8% and 2.0% annually around the world. By 2035, it is estimated that more than 2.5 million new cases of BC will occur annually. In Egypt, the age-adjusted rate of BC is 49.6 per 100.000 populations and the median age for diagnosis is younger than European countries and most women patients are premenopausal.
BC has been identified as a major public health problem in both developed and developing nations because of its high incidence–prevalence, the over-burdened health system, and direct medical expenditure. It is made distinct from other types of cancers by the fact that it occurs in a noticeable organ and can be detected and treated at an early stage. It cannot be prevented, but it can be effectively treated and even cured if detected early more treatable stage. Early diagnosis of BC is critical to reducing the cost of treatments reducing cancer-related mortality and increases survival rates, particularly where radiation, hormonal, and chemotherapy are not widely available.
Screening mammography is a low-dose X-ray examination of a woman's breasts used to detect BC when that cancer is too small to be felt as a lump. The American College of Radiology and American Cancer Society recommend yearly screening mammography starting at age 40 years and strongly recommend annual mammography screening for women aged 45–54 years and biennial mammography screening starting at age 55 years., Screening mammography is very useful as it reduces mortality from BC by about 20%–35% in women aged 50–69 years and slightly less in women aged 40–49 years at a period of 14 years of follow-up.
In Egypt, facilities for mammographic screening are available in the major governmental and private hospitals and delivered through mobile units equipped with digital mammography units. Despite these mobile units, which increase the presence in rural areas and less affluent areas, barriers to accessing mammography still exist.
Various factors affect the rates of Ms such as age, educational level, income, ethnic origin, insurance status, marital status, and health status are important factors influencing the uptake of screening services for BC. Other factors include socioeconomic characteristics, utilization of health services, healthy elated behavior, and self-assessed health status. Mammography screening rates in developed countries range between 15 and 79%, while they are <5% in developing countries. The important issue for the prevention of death from BC is the development of strategies to increase BC screening rates. To increase participation in BC screening, the study aimed to analyze factors that affect MS utilization among educated women.
| Patients and Methods|| |
A community-based crosssectional interview survey was conducted in Al Beheira governorate Egypt. A cluster sampling technique was used. Ten districts (of 15 districts) were randomly selected, two clusters from each district (one rural and another urban). Sample from each cluster was proportionate to its size each to represent the women in rural and urban areas. The sample size was determined using Epi info, version 7.1.5, 2015 (CDC). The minimum required sample size was 369, based on the assumption that the mammography screening utilization rate among women was 60%, the precision was 5%, and 95% confidence level. A total of 700 women were randomly selected. Educated women (secondary education and above) aged 40 years and older who accepted to participate were included in the study. Women were categorized into “ever screeners” if they had even used mammogram screening and “ever screeners” if not.
A predesigned interviewing questionnaire was used to collect data from the participants including their sociodemographic data (age of the participants, level of education, residence, employment status, income, health insurance, menopausal status, history of previous breast disease, family history of BC lack of access or time, and lack of social support) and cultural norm and knowledge about mammography screening. The questionnaire was tested through a pilot study of thirty women to detect any difficulties or confusing questions for modification or deletion.
Data were analyzed using SPSS software, version 16.0 (SPSS Inc., Chicago, IL, USA). Univariate analysis was used to compare variables for the outcomes of interest. Continuous data were compared using the Student's t-test. Either Chi-square or Fisher's exact tests were used to compare categorical variables. A multivariate analysis (logistic regressions enter approach) was performed to determine the predictor variable. The results were considered to be statistically significant at P < 0.05 at confidence interval 95%.
| Results|| |
A total of 700 women above 40 years were included in this study. Fifty percent of the participants resided in rural areas. Participants were aged between 40 and 68 years (mean age 49.5 + 6.5 years) and nearly 50% had a university degree. [Table 1] shows that there was a statistically significant association (P > 0.005) between the age of the participants, level of education, and residence and MS status of the participants. The difference between ever screener and never screener groups was statistically significant regarding employment status and income. Females have health insurance or a history of previous breast disease, were utilize MS significantly (P < 0.05) more than females who haven't. Furthermore, lack of access or time and lack of social support were significantly (P < 0.05) different between the studied groups. [Table 2] shows that regarding the cultural norm and knowledge about mammography, fear of embarrassment, positive result of MS, and fear of treatment were significantly (P < 0.01) higher in never screener women than ever screener women. Incorrect or lack of knowledge about BC or MS was highly statistically significant (P < 0.001) different between the studied groups. Multivariate logistic regression revealed that lack of knowledge about mammography (odds ratio [OR] = 9.8), education level (OR = 6.0), employment status (OR = 3.5), cancer fatalism (OR = 3.0), residence (OR = 2.8), fear of embarrassment (OR = 2.6, fear of positive result (OR = 2.4), family income (OR = 1.9), and health insurance (OR = 1.8) were significant predictors (P < 0.05) of mammography screening utilization [Table 3].
|Table 2: Cultural norm and knowledge about mammography screening differences between the study groups**|
Click here to view
|Table 3: Factors independently associated with mammogram screening by multivariate logistic regression analysis result|
Click here to view
| Discussion|| |
BC is the leading cancer in women worldwide and is increasing, particularly in developing countries where the majority of cases are diagnosed in late stages. Early detection by screening mammography and treatment of the disease have been shown to decrease mortality rates. The age at which screening mammography should commence remains controversial. Most countries recommend starting this screening modality between the ages of 40 and 50 years.
In the current study, 14% of the participants reported ever having a mammogram screening. This finding is lower than that reported in Saudi Arabia (40%) and very lower than that in Sweden (92%) and Denmark (79%).
Sociodemographic factors of participants (age, education level, family income, and residence) were statistically significant differences between ever screener and never screener groups. This in agreement with many studies., Employment status was statistical significance with MS participation. This may be due to higher income and health insurance accompanied by employment. This is coincides with other studies, while Ersin et al. showed no difference between employed and nonemployed. There was a statistically significant difference between the study groups regarding the menopausal status and personal history of breast disease with MS utilization. This finding is consistent with previous studies reports. Lack of access to screening services (a lack of a nearby facility, health-care provider recommendation, or lack of time) was statistically significant difference between ever screener and never screener group with utilization of MS. Li C et al. stated that MS participation my influenced by distance between the residence and the screening unit which is a major challenge in low- and middle-income countries. Women who did not have health insurance were less likely to undergo mammography than those who have it. This result is supported by other studies that reported a lack of health insurance as a significant predictor of no adherence. Patients without health insurance were less likely to have a regular source of health care, while people with a trusted source of care that they access regularly were more likely to be referred for screening services. Social support for health can includes both functional support, such as having others to provide transportation to medical appointments, and emotional support, such as having others available to discuss breast health or to give medical advice. Lack of knowledge about BC and percentage of women who believed that the treatment for cancer is worse than cancer were statistically significant different between our study groups. Furthermore, women having a lack of knowledge about mammography were less likely participate in mammography screening. This is line with another study. Regarding cultural norms and belief, women having negative cultural (cancer fatalism) and fear of embarrassment or fear of receiving a cancer were less likely to undergo mammography than women have not. Cancer fatalism: Cancer fatalism is the belief that a cancer diagnosis means that death is inevitable. Cultural taboo and women's fear of mastectomy or losing a breast were identified as barriers to screening.
| Conclusion|| |
The mammography utilization screening rate is low. Although the participants were educated female, the lack of knowledge about mammography and cultural norms were the main barriers to mammography screening.
Education programs or sessions for females, especially for those living in the rural area to improve their culture and knowledge about BC and mammogram screening after 40 years. Providing free mammography screening services to targeting the risk groups (low educated, have low-income, noninsured women, and living in rural areas) to remove the financial and accessibility barriers.
First, the study used a cross-sectional design. Second, the sample was not representative all the Egyptian population as it was conducted in one governorate only. Third, women's self-report was in compliance with mammography use, so they might suffer from reporting bias.
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and met the ethical standard outlines in Helsinki Declaration of 1975 as revised in 2000. The purpose of the study was explained to all and they were informed that all collected data will be used for scientific purpose only. They were ensured strict confidentiality and anonymity before proceeding in the interview.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
Azamjah N, Soltan-Zadeh Y, Zayeri F. Global trend of breast cancer mortality rate: A 25-year study. Asian Pac J Cancer Prev 2019;20:2015-20.
Tessmer MS, Anderson KC. AACR cancer progress report 2016: Improving lives through research. Clin Cancer Res 2016;22:4759.
Manzour AF, Eldin DA. Awareness about breast cancer and mammogram among women attending outpatient clinics, Ain Shams University Hospitals, Egypt. J Egypt Public Health Assoc 2019;94:26.
Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133-45.
Milosevic M, Jankovic D, Milenkovic A, Stojanov D. Early diagnosis and detection of breast cancer. Technol Health Care 2018;26:729-59.
Antony MP, Surakutty B, Vasu TA, Chisthi M. Risk factors for breast cancer among Indian women: A case – Control study. Niger J Clin Pract 2018;21:436-42.
] [Full text]
Koc G, Gulen-Savas H, Ergol S, Yildirim-Cetinkaya M, Aydin N. Female university students' knowledge and practice of breast self-examination in Turkey. Niger J Clin Pract 2019;22:410-5.
] [Full text]
Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al
. Breast cancer screening for women at average risk: 2015 Guideline Update From the American Cancer Society. JAMA 2015;314:1599-614.
Mamdouh HM, El-Mansy H, Kharboush IF, Ismail HM, Tawfik MM, El-Baky MA, et al
. Barriers to breast cancer screening among a sample of Egyptian females. J Fam Community Med 2014;21:119-24.
] [Full text]
Women's Health Outreach Program. Women's Health Outreach Program for Egypt; 2014. Available from: http://www.whop.gov.eg
. [Last accessed on 2019 Mar 25].
Abda N, Najdi A, El Fakir S, Tachfouti N, Berraho M, Khazraji YC, et al.
Knowledge, attitudes, and preventive practice towards breast cancer among general practitioner health professionals in Morocco. Asian Pacific journal of cancer prevention: APJCP 2017;18:963.
Patel K. Factors influencing breast cancer screening in low-income African Americans in Tennessee. J Community Health 2014;39:943-50.
Bawazir A, Bashateh N, Jradi H, Breik AB. Breast cancer screening awareness and practices among women attending primary health care Centers in the Ghail Bawazir District of Yemen. Clin Breast Cancer 2019;19:e20-9.
Hassoun Y, Dbouk H, Aldin E, Nasser Z, Abbas L, Nahleh Z, et al
. Barriers to mammography screening: How to overcome them. Middle East J Cancer 2015;6:243-51.
Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, et al
. Factors affecting breast cancer treatment delay in Turkey study from Turkish Federation of Breast Diseases Societies. Eur J Public Health 2015;25:9-14.
Al-Wassia RK, Farsi NJ, Merdad LA, Hagi SK. Patterns, knowledge, and barriers of mammography use among women in Saudi Arabia. Saudi Med J 2017;38:913-21.
Wang WL, Hsu SD, Wang JH, Huang LC, Hsu WL. Survey of breast cancer mammography screening behaviors in Eastern Taiwan based on a health belief model. Kaohsiung J Med Sci 2014;30:422-7.
Leung J, McKenzie S, Martin J, McLaughlin D. Effect of rurality on screening for breast cancer: A systematic review and meta-analysis comparing mammography. Rural Remote Health 2014;14:2730.
Abdelaziz SH, Youssef NF, Hassan NA, Rahman RW. Factors associated with mammography screening behaviors: A cross sectional descriptive study of Egyptian women. Int J Med Health Biomed Bioeng Pharm Eng 2015;9:401-7.
Ersin F, Gözükara F, Polat P, Erçetin G, Bozkurt ME. Determining the health beliefs and breast cancer fear levels of women regarding mammography. Turk J Med Sci 2015;45:775-81.
Wu Z, Liu Y, Li X, Song B, Ni C. et al
. Factors associated with breast cancer screening participation among women in mainland China: a systematic review. BMJ open 2019;9:e028705.
Cheng J. Profile and Predictors of Breast Cancer Opportunistic Screening Utilization among Female in Tianjin Community. The Master's Thesis. Tianjin: Tianjin Medical University; 2018.
[Table 1], [Table 2], [Table 3]